Symptomatic exacerbation of Crohn disease after treatment with high-dose interleukin-2

J. A. Sparano, L. J. Brandt, J. P. Dutcher, J. S. DuBois, M. B. Atkins

Research output: Contribution to journalArticle

29 Scopus citations


Two patients treated with high-dose interleukin-2 (IL-2), who had a history of Crohn disease that was clinically quiescent for 4 and 9 years before therapy, developed symptomatic reactivation of Crohn disease requiring surgical intervention.

Original languageEnglish (US)
Pages (from-to)617-618
Number of pages2
JournalAnnals of internal medicine
Issue number8
StatePublished - Jan 1 1993


ASJC Scopus subject areas

  • Internal Medicine

Cite this